Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group
Büchner, T.; Hiddemann, W.; Löffler, G.; Gassmann, W.; Maschmeyer, G.; Heit, W.; Hossfeld, D.; Weh, H.; Ludwig, W.D.; Thiel, E.
Seminars in Hematology 28(3 Suppl 4: 76-79
1991
ISSN/ISBN: 0037-1963 PMID: 1780757 Document Number: 384191
Document emailed within 1 workday
Related Documents
Büchner, T.; Hiddemann, W.; Wörmann, B.; Löffler, H.; Maschmeyer, G.; Hossfeld, D.; Ludwig, W.D.; Nowrousian, M.; Aul, C.; Schaefer, U.W. 1992: Longterm effects of prolonged maintenance and of very early intensification chemotherapy in AML: data from AMLCG Leukemia 6(Suppl 2): 68-71Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40
Machover, D.; Schwarzenberg, L.; D'Hubert, E.; Lemaigre, G.; Caillou, B.; Tourani, J.M.; Michalski, B.; Goldschmidt, E.; Gaget, H.; De Vassal, F.; Misset, J.L.; Dorval, T.; Ribaud, P.; Jasmin, C.; Hayat, M.; Rappaport, H.; Mathé, G. 1982: Treatment of acute myeloid leukemia with a protocol combining intensive induction chemotherapy, early consolidation treatment, splenectomy and long-term maintenance chemotherapy. Preliminary study La Nouvelle Presse Medicale 11(52): 3835-3839
Harousseau, J.L.; Pignon, B.; Cahn, J.Y. 1993: Comparison between bone marrow autograft and intensive chemotherapy as treatment for maintenance of complete remission in acute myeloblastic leukemia in the adult. GOELAM Group Nouvelle Revue Francaise d'Hematologie 35(3): 197-198
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352
Invernizzi, R.; Rosanda, C.; Basso, G.; Conter, V.; di Cataldo, A.; Fenu, S.; Forni, M.; Frappampina, V.; Granchi, D.; Locatelli, F. 1992: Granular acute lymphoblastic leukemia in children. "Aieop Cooperative Group for Cytology of Acute Leukemias" Haematologica 77(1): 30-34
Kimura, K. 1987: A phase Ii study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(8): 2475-2481
Arlin, Z.; Case, D.C.; Moore, J.; Wiernik, P.; Feldman, E.; Saletan, S.; Desai, P.; Sia, L.; Cartwright, K. 1990: Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group Leukemia 4(3): 177-183
Ducastelle, S.; Adès, L.; Gardin, C.; Dombret, Hé.; Prébet, T.; Deconinck, E.; Rio, B.; Thomas, X.; Debotton, S.; Guerci, Aès.; Gratecos, N.; Stamatoullas, A.; Fegueux, N.; Dreyfus, Fçois.; Fenaux, P.; Wattel, E. 2006: Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia Haematologica 91(3): 373-376
Zittoun, R.; Mandelli, F.; Willemze, R.; de Witte, T.; Tura, S.; Ferrini, P.R.; Stryckmans, P.; Gattringer, C.; Petti, M.C.; Solbu, G. 1992: Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase IIi trial (AML8 A). the EORTC Leukemia Cooperative Group and the GIMEMA Group Leukemia 6(Suppl 2): 114-115
Musso, M.; Porretto, F.; Crescimanno, A.; Bondì, F.; Polizzi, V.; Scalone, R.; Tolomeo, M.; Mariani, G. 1997: Low-dose long-term oral idarubicin in maintenance treatment of elderly acute myeloid leukemia Haematologica 82(5 Suppl): 4-8
Michalová, K.; Musilová, J.; Zemanová, Z. 1990: Cytogenetic abnormalities in 532 patients with myeloid leukemias and myelodyplastic syndrome. the Czechoslovak MDS Cooperative Group Czechoslovak Medicine 13(4): 133-144
Ringdén, O.; Labopin, M.; Gluckman, E.; Reiffers, J.; Vernant, J.P.; Jouet, J.P.; Harrousseau, J.L.; Fiere, D.; Bacigalupo, A.; Frassoni, F.; Gorin, N.C. 1996: Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin a combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplantation 18(5): 921-929
Suciu, S.; Solbu, G.; Zittoun, R.; Hayat, M.; Willemze, R.; de Witte, T.; Mandelli, F. 1991: Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA Bone Marrow Transplantation 7(Suppl 2): 34
Mejía-Aranguré, J.Manuel.; Núñez-Enríquez, J.Carlos.; Fajardo-Gutiérrez, A.; Rodríguez-Zepeda, Mía.Del.Carmen.; Martín-Trejo, J.Alfonso.; Duarte-Rodríguez, D.Aldebarán.; Medina-Sansón, A.; Flores-Lujano, J.; Jiménez-Hernández, E.; Núñez-Villegas, N.Nancy.; Pérez-Saldívar, Mía.Luisa.; Paredes-Aguilera, R.; Cárdenas-Cardós, Río.; Flores-Chapa, Jé.de.Diego.; Reyes-Zepeda, N.Carolina.; Flores-Villegas, L.Victoria.; Amador-Sánchez, R.; Torres-Nava, Jé.Refugio.; Bolea-Murga, V.; Espinosa-Elizondo, R.Martha.; Peñaloza-González, Jé.Gabriel.; Velázquez-Aviña, M.Margarita.; González-Bonilla, César.; Békker-Méndez, V.Carolina.; Jiménez- 2016: Descriptive epidemiology of children with acute myeloid leukemia residing in Mexico City: a report from the Mexican Inter-Institutional Group for Identifying Childhood Leukemia Causes Gaceta Medica de Mexico 152(Suppl. 2): 66-77
Hines, J.D.; Mazza, J.J.; Oken, M.M.; Bennett, J.M.; Adelstein, D.J.; Keller, A.; O'Connell, M.J. 1985: High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase i Pilot Study for the Eastern Cooperative Oncology Group Seminars in Oncology 12(2 Suppl 3: 117-119
Garshick, M.; DeFilippis, E.M.; Harp, J.; Gaan, J. 2014: Eccrine poromatosis in a patient with acute myeloid leukemia following chemotherapy Dermatology Online Journal 20(11)
Kerr, A.; Vasudevan, V.P.; Powell, S.; Ligenza, C. 1991: Percutaneous catheter drainage for acute empyema. Improved cure rate using CAT scan, fluoroscopy, and pigtail drainage catheters New York State Journal of Medicine 91(1): 4-7
Hołowiecki, J.; Duraj, M.; Rudzka, E.; Jarczok, K.; Krawczyk, M.; Hołowiecka, B.; Kniewska, I.; Kuśnierczyk, J.; Opala, G.; Stańczuk, M. 1984: Cooperative randomized studies on the treatment of adult acute leukemia in Poland. a comparison of two remission induction regimes and two maintenance regimes for AML Folia Haematologica 111(2): 201-207
Schiffer, C.A.; Davis, R.B.; Mayer, R.J.; Peterson, B.A.; Lee, E.J. 1987: Combination chemotherapy with diaziquone and amsacrine in relapsed and refractory acute nonlymphocytic leukemia: a Cancer and Leukemia Group B Study Cancer Treatment Reports 71(9): 879-880